Get started
Author

Nadide Colak Ergun

Observed names: NADİDE ERGUN, Nadide Ergün
ORCID: 0000-0002-2105-8004
Observed ORCID: 0000-0002-2105-8004
OpenAlex ID: A5064403876
Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience
2019 · Bengu Tatar, Şükran Köse, et al. · Revista da Associação Médica Brasileira · 8
PDF
Epidemiological profile and clinical outcomes of patients with mucormycosis: the multicenter retromucor study from Türkiye (2004–2024)
2026 · Yeliz Çiçek, Rıdvan Dumlu, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 3
PDF
Late HIV Diagnosis and Its Impact on Immune Recovery and Clinical Outcomes: A Retrospective Study From Turkey
2025 · Nadide Ergün, Gürsel Ersan · Journal of the International Association of Providers of AIDS Care (JIAPAC) · 3
Rapid virologic response in chronic hepatitis C genotype 1: Evaluation of pretreatment factors in patients
2020 · Melda Turken, Sukran Kose, et al. · Arab Journal of Gastroenterology · 2
Predictors of Candida auris Infection in Previously Colonized Patients: A Retrospective Cohort Study from a Large Tertiary Reference Center
2026 · Nadide Ergün, Sevim Karabulut, et al. · Journal of Fungi
PDF
Zoonosis Surveillance in the Digital Age: Artificial Intelligence, Digital Surveillance and Early Warning Systems
2026 · SÜHEYLA SERİN SENGER, NADİDE ERGUN · Turkiye Klinikleri eBooks
Works count: 6
Citation count: 16
H-index: 3
I10-index:
Year
Topic
Type